The DOI matches its Crossref record; 147 of the 148 references it cites were found in a registry or an index.
Lytic cell death in metabolic liver disease
Open accessAbstract
Regulated cell death is intrinsically associated with inflammatory liver disease and is pivotal in governing outcomes of metabolic liver disease. Different types of cell death may coexist as metabolic liver disease progresses to inflammation, fibrosis, and ultimately cirrhosis. In addition to apoptosis, lytic forms of hepatocellular death, such as necroptosis, pyroptosis and ferroptosis elicit strong inflammatory responses due to cell membrane permeabilisation and release of cellular components, contributing to the recruitment of immune cells and activation of hepatic stellate cells. The control of liver cell death is of fundamental importance and presents novel opportunities for potential therapeutic intervention. This review summarises the underlying mechanism of distinct lytic cell death modes and their commonalities, discusses their relevance to metabolic liver diseases of different aetiologies, and acknowledges the limitations of current knowledge in the field. We focus on the role of hepatocyte necroptosis, pyroptosis and ferroptosis in non-alcoholic fatty liver disease, alcohol-associated liver disease and other metabolic liver disorders, as well as potential therapeutic implications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Damaged and dying hepatocytes release damage-associated molecular patterns (DAMPs); potent activators of the innate immune system (209).”
From The liver as a central "hub" of the immune system: pathophysiological implications (2025) · cites this paper as [209]
In the citing paper
“These pathways involve rapid membrane permeabilization and release of cytoplasmic contents, triggering a stronger immune response than apoptosis (12).”
From Hepatic Stellate Cell-Immune Interactions in NASH (2022) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Shulga, N., & Pastorino, J. G. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.580175 · Cited by 14 · cited 1×
“Pyroptosis triggered by gut-derived PAMPS and by metabolic-derived DAMPs (ATP and uric acid) resulted in release of inflammasome-dependent cytokines from immune cells in ALD patients and in cells exposed to ethanol [120, 122].”
BackgroundRetractedFerroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691 · cited 5×
“Ferroptosis can be induced either in a canonical way by a direct or indirect inactivation of the glutathione peroxidase 4 (GPX4), the major protective mechanism of biological membranes against peroxidation damage, or in a non-canonical manner by increasing the labile iron pool [48].”
BackgroundInfluentialRegulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713 · cited 1×
“By indirectly blocking the Xc− transporter, erastin inhibits GSH synthesis, which is used by GPX4 to eliminate the production of phospholipid hydroperoxides (PL-OOH), the major mediator of chain reactions in lipoxygenases [53].”
BackgroundGalluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Self-citationCleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., Zhuang, Y., Cai, T., Wang, F., & Shao, F. (2015) · Nature · doi:10.1038/nature15514 · Cited by 6,659 · cited 4×
“Caspases-1 and -11 cleave GSDMD into a 31-kDa N-terminal GSDMDNT fragment, which exhibits intrinsic pore-forming activity, and a 22-kDa C-terminal GSDMDCT fragment that binds to GSDMDNT to maintain the protein in an inhibitory state [40, 41].”
BackgroundInfluentialMechanisms of NAFLD development and therapeutic strategies
Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354 · cited 1×
“Although metabolic alterations caused by free fatty acid overload is considered a major cause for hepatocyte damage, the mechanisms driving disease progression from simple steatosis to NASH remain incompletely understood [72].”
BackgroundACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition
Doll, S., Proneth, B., Tyurina, Y. Y., Panzilius, E., Kobayashi, S., Ingold, I., Irmler, M., Beckers, J., Aichler, M., Walch, A., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2239 · Cited by 4,293
Ferroptosis: process and function
Xie, Y., Hou, W., Song, X., Yu, Y., Huang, J., Sun, X., Kang, R., & Tang, D. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.158 · Cited by 3,727
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
Bersuker, K., Hendricks, J. M., Li, Z., Magtanong, L., Ford, B., Tang, P. H., Roberts, M. A., Tong, B., Maimone, T. J., Zoncu, R., et al. (2019) · Nature · doi:10.1038/s41586-019-1705-2 · Cited by 3,703 · cited 1×
“Recently, the ferroptosis suppressor protein 1 (FSP1), previously known as apoptosis-inducing factor mitochondrial 2 (AIFM2), was identified as a key component of a non-mitochondrial CoQ10 (ubiquinone) antioxidant system that acts in parallel to the GPX4 canonical pathway to halt the progression of lipid peroxides [58…”
BackgroundCaspase-11 cleaves gasdermin D for non-canonical inflammasome signalling
Kayagaki, N., Stowe, I. B., Lee, B. L., O’Rourke, K., Anderson, K., Warming, S., Cuellar, T., Haley, B., Roose-Girma, M., Phung, Q. T., et al. (2015) · Nature · doi:10.1038/nature15541 · Cited by 3,686 · cited 2×
“Caspases-1 and -11 cleave GSDMD into a 31-kDa N-terminal GSDMDNT fragment, which exhibits intrinsic pore-forming activity, and a 22-kDa C-terminal GSDMDCT fragment that binds to GSDMDNT to maintain the protein in an inhibitory state [40, 41].”
BackgroundInflammasomes: mechanism of assembly, regulation and signalling
Broz, P., & Dixit, V. M. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.58 · Cited by 3,500 · cited 1×
“Pyroptosis is activated by canonical and non-canonical signalling pathways, which differ in the use of cytoplasmic multiprotein complexes named inflammasomes (Figure 2) [44, 45].”
BackgroundFSP1 is a glutathione-independent ferroptosis suppressor
Doll, S., Freitas, F. P., Shah, R., Aldrovandi, M., da Silva, M. C., Ingold, I., Goya Grocin, A., Xavier da Silva, T. N., Panzilius, E., Scheel, C. H., et al. (2019) · Nature · doi:10.1038/s41586-019-1707-0 · Cited by 3,341
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327 · cited 1×
“Nevertheless, secondary products of lipid peroxidation, such as malondialdehyde and 4-hydroxinonenal are utilized as oxidative stress markers in NASH patients [103], and Vitamin E, an antioxidant that suppresses lipid peroxidation, reduces serum ALT in NASH patients [104].”
BackgroundPyroptosis: host cell death and inflammation
Bergsbaken, T., Fink, S. L., & Cookson, B. T. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2070 · Cited by 3,288 · cited 4×
“In this pathway, GSDMDNT also activates the NLRP3 inflammasome and thereby caspase-1-dependent maturation of IL-1β and IL-18.”
BackgroundInfluentialChemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin
Wang, Y., Gao, W., Shi, X., Ding, J., Liu, W., He, H., Wang, K., & Shao, F. (2017) · Nature · doi:10.1038/nature22393 · Cited by 3,199 · cited 2×
“Since this discovery, the number of pyroptotic caspases (as opposed to apoptotic caspases) has considerably increased, including caspase-1, caspase-11 and its human orthologs caspase-4 and 5 [35, 36], and even more surprisingly the apoptotic effector caspase-3 under specific circumstances [37, 38].”
BackgroundChemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., & Yuan, J. (2005) · Nature Chemical Biology · doi:10.1038/nchembio711 · Cited by 3,068 · cited 1×
“showed that necrostatin-1, a chemical compound that blocks the kinase activity of RIPK1, was able to inhibit cell death in TNF-treated cell lines [7].”
BackgroundSterile inflammation: sensing and reacting to damage
Chen, G. Y., & Nuñez, G. (2010) · Nature Reviews Immunology · doi:10.1038/nri2873 · Cited by 3,051 · cited 14×
“However, further investigations are needed to identify which specific DAMPs might preferentially activate one lytic RCD or another.”
BackgroundInfluentialOxidized arachidonic and adrenic PEs navigate cells to ferroptosis
Kagan, V. E., Mao, G., Qu, F., Angeli, J. P. F., Doll, S., Croix, C. S., Dar, H. H., Liu, B., Tyurin, V. A., Ritov, V. B., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2238 · Cited by 3,029
Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
Sun, L., Wang, H., Wang, Z., He, S., Chen, S., Liao, D., Wang, L., Yan, J., Liu, W., Lei, X., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.031 · Cited by 2,698
The molecular machinery of regulated cell death
Tang, D., Kang, R., Berghe, T. V., Vandenabeele, P., & Kroemer, G. (2019) · Cell Research · doi:10.1038/s41422-019-0164-5 · Cited by 2,675 · cited 3×
“Consequently, RIPK3 mediates the phosphorylation of MLKL, resulting in MLKL oligomerization and translocation to the plasma membrane [13].”
BackgroundInfluentialMechanisms and Functions of Inflammasomes
Lamkanfi, M., & Dixit, V. M. (2014) · Cell · doi:10.1016/j.cell.2014.04.007 · Cited by 2,579 · cited 1×
“Pyroptosis is activated by canonical and non-canonical signalling pathways, which differ in the use of cytoplasmic multiprotein complexes named inflammasomes (Figure 2) [44, 45].”
BackgroundNon-canonical inflammasome activation targets caspase-11
Kayagaki, N., Warming, S., Lamkanfi, M., Walle, L. V., Louie, S., Dong, J., Newton, K., Qu, Y., Liu, J., Heldens, S., et al. (2011) · Nature · doi:10.1038/nature10558 · Cited by 2,530 · cited 1×
“Since this discovery, the number of pyroptotic caspases (as opposed to apoptotic caspases) has considerably increased, including caspase-1, caspase-11 and its human orthologs caspase-4 and 5 [35, 36], and even more surprisingly the apoptotic effector caspase-3 under specific circumstances [37, 38].”
BackgroundInflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435
Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis
Yang, W. S., Kim, K. J., Gaschler, M. M., Patel, M., Shchepinov, M. S., & Stockwell, B. R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603244113 · Cited by 2,329
Inflammatory caspases are innate immune receptors for intracellular LPS
Shi, J., Zhao, Y., Wang, Y., Gao, W., Ding, J., Li, P., Hu, L., & Shao, F. (2014) · Nature · doi:10.1038/nature13683 · Cited by 2,285 · cited 1×
“Since this discovery, the number of pyroptotic caspases (as opposed to apoptotic caspases) has considerably increased, including caspase-1, caspase-11 and its human orthologs caspase-4 and 5 [35, 36], and even more surprisingly the apoptotic effector caspase-3 under specific circumstances [37, 38].”
BackgroundReceptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α
He, S., Wang, L., Miao, L., Wang, T., Du, F., Zhao, L., & Wang, X. (2009) · Cell · doi:10.1016/j.cell.2009.05.021 · Cited by 2,214
Lu, S. C.-L. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.09.008 · Cited by 2,192 · cited 1×
“In cells, cysteine is required for the synthesis of glutathione (GSH), a major redox regulatory system [52].”
BackgroundGlutaminolysis and transferrin regulate ferroptosis
Gao, M., Monian, P., Quadri, N., Ramasamy, R., & Jiang, X. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.06.011 · Cited by 2,069 · cited 1×
“In the non-canonical pathway, increased iron uptake by transferrin receptor (TFRC) and reduced iron export by ferroportin promote oxidative damage and ferroptosis [60, 61].”
BackgroundHoller, N., Zaru, R., Micheau, O., Thome, M., Attinger, A., Valitutti, S., Bodmer, J.-L., Schneider, P., Seed, B., & Tschopp, J. (2000) · Nature Immunology · doi:10.1038/82732 · Cited by 1,987
Ferroptosis, a new form of cell death: opportunities and challenges in cancer
Mou, Y., Wang, J., Wu, J., He, D., Zhang, C., Duan, C., & Li, B. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0720-y · Cited by 1,964 · cited 1×
“A substantial number of DAMPs, including HMGB1, heat shock proteins (HSPs), ATP, and interleukins, have been differentially involved in pyroptosis, necroptosis or ferroptosis [65, 66].”
BackgroundRIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis
Zhang, D.-W., Shao, J., Lin, J., Zhang, N., Lu, B.-J., Lin, S.-C., Dong, M.-Q., & Han, J. (2009) · Science · doi:10.1126/science.1172308 · Cited by 1,931
Regulated necrosis: the expanding network of non-apoptotic cell death pathways
Berghe, T. V., Linkermann, A., Jouan-Lanhouet, S., Walczak, H., & Vandenabeele, P. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3737 · Cited by 1,735 · cited 1×
“However, recent findings highlight multiple forms of regulated necrotic modalities, including necroptosis, pyroptosis and ferroptosis, that share key morphologic features with passive necrosis yet have welldefined and regulated causal mechanisms [2, 3].”
BackgroundThe gasdermins, a protein family executing cell death and inflammation
Broz, P., Pelegrín, P., & Shao, F. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0228-2 · Cited by 1,641 · cited 2×
“Although most of the gasdermins have been associated with the occurrence and development of various diseases, their precise function and molecular mechanism of activation remain largely unknown [43].”
BackgroundRogers, C., Fernandes-Alnemri, T., Mayes, L., Alnemri, D., Cingolani, G., & Alnemri, E. S. (2017) · Nature Communications · doi:10.1038/ncomms14128 · Cited by 1,510 · cited 1×
“Since this discovery, the number of pyroptotic caspases (as opposed to apoptotic caspases) has considerably increased, including caspase-1, caspase-11 and its human orthologs caspase-4 and 5 [35, 36], and even more surprisingly the apoptotic effector caspase-3 under specific circumstances [37, 38].”
BackgroundDolma, S., Lessnick, S. L., Hahn, W. C., & Stockwell, B. R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00050-3 · Cited by 1,446 · cited 1×
“Ferroptosis was originally observed in 2003 using erastin, a cell-permeable compound, which was only lethal to engineered human tumour cells expressing an oncogenic RAS mutation [47].”
Pro-inflammatory programmed cell death
Cookson, B. T., & Brennan, M. A. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01936-3 · Cited by 1,422 · cited 1×
“However, the term has emerged nearly a decade later, in 2001, when Cookson and Brennan demonstrated that Salmonellainduced macrophage death was dependent on caspase-1 [34].”
BackgroundPlasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis
Cai, Z., Jitkaew, S., Zhao, J., Chiang, H.-C., Choksi, S., Liu, J., Ward, Y., Wu, L.-G., & Liu, Z.-G. (2014) · Nature Cell Biology · doi:10.1038/ncb2883 · Cited by 1,322 · cited 1×
“Finally, MLKL forms pore in the plasma membrane [16, 17], and increases permeability via the activation of A disintegrin and metalloproteinase (ADAM) proteases [18], Ca2+ influx by targeting the cation channel transient receptor potential melastatin related 7 (TRPM7) [19], and phosphatidylserine externalization [20].”
BackgroundShigella flexneri induces apoptosis in infected macrophages
Zychlinsky, A., Prévost, M., & Sansonetti, P. (1992) · Nature · doi:10.1038/358167a0 · Cited by 1,259 · cited 1×
“, who described a lytic form of cell death in Shigella flexneri-infected macrophages [33].”
BackgroundFerrostatins Inhibit Oxidative Lipid Damage and Cell Death in Diverse Disease Models
Skouta, R., Dixon, S. J., Wang, J., Dunn, D. E., Orman, M., Shimada, K., Rosenberg, P. A., Lo, D. C., Weinberg, J. M., Linkermann, A., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja411006a · Cited by 1,146
Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis
Fritsch, M., Günther, S. D., Schwarzer, R., Albert, M., Schorn, F., Werthenbach, J. P., Schiffmann, L. M., Stair, N., Stocks, H., Seeger, J. M., et al. (2019) · Nature · doi:10.1038/s41586-019-1770-6 · Cited by 1,122 · cited 1×
“apoptosis, necroptosis and pyroptosis, and prevents tissue damage [67, 68].”
BackgroundNLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
Mridha, A. R., Wree, A., Robertson, A. A. B., Yeh, M. M., Johnson, C. D., Van Rooyen, D. M., Haczeyni, F., Teoh, N. C.-H., Savard, C., Ioannou, G. N., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.022 · Cited by 1,110 · cited 1×
“Indeed, activation of IL-1β signalling, downstream of inflammasomes, drives liver inflammation and fibrosis in experimental NASH [93] and amplifies the response of other cytokines [100].”
BackgroundPyroptosis versus necroptosis: similarities, differences, and crosstalk
Frank, D., & Vince, J. E. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0212-6 · Cited by 1,062 · cited 1×
“A substantial number of DAMPs, including HMGB1, heat shock proteins (HSPs), ATP, and interleukins, have been differentially involved in pyroptosis, necroptosis or ferroptosis [65, 66].”
BackgroundNecroptosis in development, inflammation and disease
Weinlich, R., Oberst, A., Beere, H. M., & Green, D. R. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.149 · Cited by 1,016 · cited 1×
“Although no specific necroptotic DAMPs have been identified so far, their release during necroptosis provokes a strong inflammatory response that has been linked to the development of many diseases [12].”
BackgroundWree, A., Eguchi, A., McGeough, M. D., Pena, C. A., Johnson, C. D., Canbay, A., Hoffman, H. M., & Feldstein, A. E. (2014) · Hepatology · doi:10.1002/hep.26592 · Cited by 945 · cited 2×
“Interestingly, compared to global NLRP3 knock-in mice, mice with myeloid-specific Nlrp3 mutations lack detectable pyroptotic hepatocyte cell death and have less severe liver inflammation, HSC activation, and fibrosis [101].”
BackgroundTriggering and resolution of inflammation in NASH
Schuster, S., Cabrera, D., Arrese, M., & Feldstein, A. E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0009-6 · Cited by 943
Zhao, J., Jitkaew, S., Cai, Z., Choksi, S., Li, Q., Luo, J., & Liu, Z.-G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200012109 · Cited by 925
Alcoholic liver disease: mechanisms of injury and targeted treatment
Louvet, A., & Mathurin, P. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.35 · Cited by 867 · cited 1×
“Cell injury, inflammation, oxidative stress, regeneration and bacterial translocation are key drivers of alcohol-induced liver injury [113].”
BackgroundCleavage of the death domain kinase RIP by Caspase-8 prompts TNF-induced apoptosisPreprint
Lin, Y., Devin, A., Rodriguez, Y., & Liu, Z.-G. (1999) · Genes & Development · doi:10.1101/gad.13.19.2514 · Cited by 849 · cited 1×
“On one hand, caspase-8 cleaves and inactivates RIPK1 and RIPK3, which has for consequence to suppress necroptosis [22, 23].”
BackgroundMLKL Compromises Plasma Membrane Integrity by Binding to Phosphatidylinositol Phosphates
Dondelinger, Y., Declercq, W., Montessuit, S., Roelandt, R., Gonçalves, A. C., Bruggeman, I., Hulpiau, P., Weber, K., Sehon, C. A., Marquis, R. W., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.026 · Cited by 840 · cited 1×
“Finally, MLKL forms pore in the plasma membrane [16, 17], and increases permeability via the activation of A disintegrin and metalloproteinase (ADAM) proteases [18], Ca2+ influx by targeting the cation channel transient receptor potential melastatin related 7 (TRPM7) [19], and phosphatidylserine externalization [20].”
BackgroundCell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical Relevance
Luedde, T., Kaplowitz, N., & Schwabe, R. F. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.07.018 · Cited by 785
Unsolved mysteries: How does lipid peroxidation cause ferroptosis?
Feng, H., & Stockwell, B. R. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2006203 · Cited by 768 · cited 1×
“The reactions involving iron and leading to the hydroxyl or alkoxyl (RO ̇) radical are traditionally called Fenton reactions [54].”
BackgroundUpton, J. W., Kaiser, W. J., & Mocarski, E. S. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.01.016 · Cited by 758
He, S., Liang, Y., Shao, F., & Wang, X. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116302108 · Cited by 751 · cited 2×
“, TLR3 and TLR4) [26], nucleic acid sensors (e.”
BackgroundLi, Z., Agellon, L., Allen, T., Umeda, M., Jewell, L. S., Mason, A., & Vance, D. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.03.007 · Cited by 739 · cited 1×
“Consistently, the hepatic PC/PE ratio is decreased in NASH patients [110, 111].”
BackgroundESCRT-III Acts Downstream of MLKL to Regulate Necroptotic Cell Death and Its Consequences
Gong, Y.-N., Guy, C., Olauson, H., Becker, J. U., Yang, M., Fitzgerald, P., Linkermann, A., & Green, D. R. (2017) · Cell · doi:10.1016/j.cell.2017.03.020 · Cited by 689
Activity of Protein Kinase RIPK3 Determines Whether Cells Die by Necroptosis or Apoptosis
Newton, K., Dugger, D. L., Wickliffe, K. E., Kapoor, N., de Almagro, M. C., Vucic, D., Komuves, L., Ferrando, R. E., French, D. M., Webster, J., et al. (2014) · Science · doi:10.1126/science.1249361 · Cited by 687 · cited 1×
“, RIPK3 kinase activity inhibited) [24, 25].”
Characterization of ferroptosis in murine models of hemochromatosis
Wang, H., An, P., Xie, E., Wu, Q., Fang, X., Gao, H., Zhang, Z., Li, Y., Wang, X., Zhang, J., et al. (2017) · Hepatology · doi:10.1002/hep.29117 · Cited by 662
RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL
Lawlor, K. E., Khan, N. R., Mildenhall, A., Gerlic, M., Croker, B. A., D’Cruz, A. A., Hall, C. M., Spall, S. K., Anderton, H., Masters, S. L., et al. (2015) · Nature Communications · doi:10.1038/ncomms7282 · Cited by 660 · cited 1×
“While it appears clear that ethanol-induced necroptosis involves RIPK3, it is not yet known if MLKL-independent pathways are involved as reported in models of autoimmune arthritis [118].”
BackgroundRIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity
Mandal, P., Berger, S. B., Pillay, S., Moriwaki, K., Huang, C., Guo, H., Lich, J. D., Finger, J. N., Kasparcova, V., Votta, B. J., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.10.021 · Cited by 634 · cited 2×
“Moreover, inhibition of RIPK3 kinase often provokes apoptosis further confusing this approach in examining necroptosis in disease pertinent models [25].”
BackgroundRathkey, J. K., Zhao, J., Liu, Z., Chen, Y., Yang, J., Kondolf, H. C., Benson, B. L., Chirieleison, S. M., Huang, A. Y.-C., Dubyak, G., et al. (2018) · Science Immunology · doi:10.1126/sciimmunol.aat2738 · Cited by 623
Inflammasome activation and function in liver disease
Szabó, G., & Petrasek, J. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.94 · Cited by 600 · cited 1×
“Inflammasome activation triggers caspase activity and promotes inflammation and fibrosis in liver disease [97], while typical activators of inflammasomes such as fatty acids, DAMPs, and uric acid upregulate NLRP3 inflammasome components.”
BackgroundHildebrand, J. M., Tanzer, M. C., Lucet, I. S., Young, S. N., Spall, S. K., Sharma, P., Pierotti, C., Garnier, J.-M., Dobson, R. C. J., Webb, A. I., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408987111 · Cited by 598 · cited 1×
“Finally, MLKL forms pore in the plasma membrane [16, 17], and increases permeability via the activation of A disintegrin and metalloproteinase (ADAM) proteases [18], Ca2+ influx by targeting the cation channel transient receptor potential melastatin related 7 (TRPM7) [19], and phosphatidylserine externalization [20].”
BackgroundApoptosis and necroptosis in the liver: a matter of life and death
Schwabe, R. F., & Luedde, T. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0065-y · Cited by 582 · cited 1×
“Necroptosis is probably the best-understood form of regulated necrosis, since it shares multiple molecular components with the extrinsic apoptotic pathway and can act as a fail-safe mechanism to ensure cell death progression when apoptosis is abnormally inhibited, which may also be relevant in pathological conditions…”
BackgroundCleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis
Newton, K., Wickliffe, K. E., Dugger, D. L., Maltzman, A., Roose‐Girma, M., Dohse, M., Kömüves, L. G., Webster, J. D., & Dixit, V. M. (2019) · Nature · doi:10.1038/s41586-019-1548-x · Cited by 559 · cited 1×
“Third, caspase-8 limits necroptosis by proteolytically cleaving RIPK1 [138], and the genetic absence of caspase-8 in hepatocytes does not trigger widespread necroptosis [134].”
BackgroundTsurusaki, S., Tsuchiya, Y., Koumura, T., Nakasone, M., Sakamoto, T., Matsuoka, M., Imai, H., Yuet-Yin Kok, C., Okochi, H., Nakano, H., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1678-y · Cited by 529 · cited 1×
“In a recent study, ferroptosis inhibitors, trolox and deferiprone, suppressed necrotic cell death, infiltration of inflammatory cells, and inflammatory cytokine expression in the onset of steatohepatitis in the choline-deficient, ethionine-supplemented (CDE) diet model [108], in which hepatic cell death is an early ev…”
BackgroundKoo, G.-B., Morgan, M. J., Lee, D., Kim, W.-J., Yoon, J.-H., Koo, J. S., Kim, S. H., Kim, S., Son, M. K., Hong, S. S., et al. (2015) · Cell Research · doi:10.1038/cr.2015.56 · Cited by 500 · cited 1×
“Epigenetic silencing of RIPK3, in contrast, has been associated with malignant transformation in hepatocellular carcinoma cells, while reestablishment of RIPK3 expression by promoter demethylation resensitized cells to chemotherapy-induced necroptosis [89], again implying that induction of RIPK3 is context-dependent.”
BackgroundMechanisms of inflammasome activation: recent advances and novel insights
Vanaja, S. K., Rathinam, V. A. K., & Fitzgerald, K. A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.12.009 · Cited by 499 · cited 1×
“The canonical inflammasomes comprise a sensor protein belonging to the nucleotide-binding domain (NBD) and leucine-rich-repeat-(LRR)-containing (NLR) or the AIM2-like receptor (ALR) or pyrin family, an adaptor protein, apoptosis-associated speck-like protein containing a CARD (ASC), and an inactive zymogen, pro-caspas…”
BackgroundHepatocyte Death: A Clear and Present Danger
Malhi, H., Guicciardi, M. E., & Gores, G. J. (2010) · Physiological Reviews · doi:10.1152/physrev.00061.2009 · Cited by 477 · cited 1×
“Cell death has been described as a clear and present danger for hepatocytes as they are directly exposed to portal blood from the intestines, participate in the xenobiotic metabolism of drugs and alcohol, play a central role in lipid, fatty acid, and bile acid metabolism, contact with prevalent hepatotropic viruses, a…”
BackgroundSelf-citationCleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain
Feng, S., Yang, Y., Mei, Y., Ma, L., Zhu, D.-E., Höti, N., Castanares, M. A., & Wu, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.05.016 · Cited by 459
Xu, B., Jiang, M., Chu, Y., Wang, W., Chen, D., Li, X., Zhang, Z., Zhang, D., Fan, D., Nie, Y., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.040 · Cited by 426 · cited 2×
“In addition, liver fibrosis was strongly attenuated in Gsdmd−/− mice after MCD feeding [99].”
BackgroundTosello-Trampont, A.-C., Landes, S. G., Nguyen, V., Novobrantseva, T. I., & Hahn, Y. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.417014 · Cited by 415
NASH is an Infl ammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications
Farrell, G. C., Rooyen, D. M. V., Gan, L. T., & Chitturi, S. (2012) · Gut and Liver · doi:10.5009/gnl.2012.6.2.149 · Cited by 408
Deficient Endoplasmic Reticulum-Mitochondrial Phosphatidylserine Transfer Causes Liver Disease
Hernández‐Álvarez, M. I., Sebastián, D., Vives, S., Ivanova, S., Bartoccioni, P., Kakimoto, P. A., Plana, N., Veiga, S. R., Hernandez, V. A., Vasconcelos, N., et al. (2019) · Cell · doi:10.1016/j.cell.2019.04.010 · Cited by 407
Self-citationThe x cystine/glutamate antiporter: A potential target for therapy of cancer and other diseases
Lo, M., Wang, Y., & Gout, P. W. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21366 · Cited by 399 · cited 1×
“The Xc− transporter system is composed of a regulatory subunit solute carrier family 3 member 2 (SLC3A2) and a catalytic subunit solute carrier family 7 member 11 (SLC7A11), which promotes the cellular uptake of cystine, the plasma precursor of cysteine, by exchange with glutamate [51].”
BackgroundActivity of caspase-8 determines plasticity between cell death pathways
Newton, K., Wickliffe, K. E., Maltzman, A., Dugger, D. L., Reja, R., Zhang, Y., Roose‐Girma, M., Modrusan, Z. D., Sagolla, M. S., Webster, J. D., et al. (2019) · Nature · doi:10.1038/s41586-019-1752-8 · Cited by 383 · cited 1×
“apoptosis, necroptosis and pyroptosis, and prevents tissue damage [67, 68].”
BackgroundRIPK1 and RIPK3: critical regulators of inflammation and cell death
Newton, K. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.01.001 · Cited by 377 · cited 1×
“Other functions of RIPK3 in hepatocarcinogenesis have been recognized [85], and its involvement in inflammatory signalling independent of necroptosis and mediation of cell death should not be neglected [86, 87].”
BackgroundYoon, S., Kovalenko, A., Bogdanov, K., & Wallach, D. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.001 · Cited by 368
RIP3: a molecular switch for necrosis and inflammationPreprint
Moriwaki, K., & Chan, F. K.-M. (2013) · Genes & Development · doi:10.1101/gad.223321.113 · Cited by 364 · cited 1×
“Second, RIPK3 deficiency does not phenocopy MLKL deficiency, and hence studies with RIPK3 knockout or kinase dead knock-in mice, are not sufficient to invoke necroptosis as a cause of cell death, as RIPK3 has diverse functions [137].”
BackgroundNelson, J. E., Wilson, L., Brunt, E. M., Yeh, M. M., Kleiner, D. E., Ünalp–Arida, A., & Kowdley, K. V. (2010) · Hepatology · doi:10.1002/hep.24038 · Cited by 362 · cited 1×
“Moreover, iron accumulation from metabolic dysfunction, aggravates NASH, such as in liver siderosis observed in some NASH patients [105], and primary hemochromatosis exacerbates NASH [106], while iron removal ameliorates liver damage and serum ALT [107].”
BackgroundBonkovsky, H. L., Jawaid, Q., Tortorelli, K., LeClair, P., Cobb, J., Lambrecht, R. W., & Banner, B. F. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80032-4 · Cited by 361 · cited 1×
“Moreover, iron accumulation from metabolic dysfunction, aggravates NASH, such as in liver siderosis observed in some NASH patients [105], and primary hemochromatosis exacerbates NASH [106], while iron removal ameliorates liver damage and serum ALT [107].”
BackgroundThe Structure of the Necrosome RIPK1-RIPK3 Core, a Human Hetero-Amyloid Signaling Complex
Mompeán, M., Li, W., Li, J., Laage, S., Siemer, A. B., Bozkurt, G., Wu, H., & McDermott, A. E. (2018) · Cell · doi:10.1016/j.cell.2018.03.032 · Cited by 348
Tilg, H., Moschen, A. R., & Szabó, G. (2016) · Hepatology · doi:10.1002/hep.28456 · Cited by 319
A positive feedback loop between RIP3 and JNK controls non‐alcoholic steatohepatitis
Gautheron, J., Vucur, M., Reisinger, F., Cardenas, D. V., Roderburg, C., Koppe, C., Kreggenwinkel, K., Schneider, A. T., Bartneck, M., Neumann, U. P., et al. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201403856 · Cited by 314 · cited 3×
“JNK activation was implicated in RIPK3-dependent liver damage and fibrosis in methionine-choline deficient (MCD) diet-fed mice, since inhibition of JNK diminished RIPK3 levels in the liver [75].”
BackgroundSelf-citationViral infection and the evolution of caspase 8-regulated apoptotic and necrotic death pathways
Mocarski, E. S., Upton, J. W., & Kaiser, W. J. (2011) · Nature reviews. Immunology · doi:10.1038/nri3131 · Cited by 309 · cited 1×
“These unexpected roles of caspase-8 involves the activation of the inflammasome and induction of pyroptosis under circumstances in which apoptosis and necroptosis are compromised, such as when the abundance of viral inhibitors may have driven the counteradaptation of pyroptosis as a host defence [70].”
BackgroundAbsence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury
Roychowdhury, S., McMullen, M. R., Pisano, S. G., Liu, X., & Nagy, L. E. (2013) · Hepatology · doi:10.1002/hep.26200 · Cited by 304 · cited 3×
“Necroptosis—The involvement of necroptosis has been suggested from studies where RIPK3 expression was induced in human ALD and in mice after ethanol exposure [84, 114].”
BackgroundResultAccumulation of natural killer T cells in progressive nonalcoholic fatty liver disease
Syn, W.-K., Oo, Y. H., Pereira, T. A., Karaca, G. F., Jung, Y., Omenetti, A., Witek, R. P., Choi, S. S., Guy, C. D., Fearing, C. M., et al. (2010) · Hepatology · doi:10.1002/hep.23599 · Cited by 283 · cited 1×
“In this regard, activation of resident Kupffer cells and infiltrating macrophages is a remarkable feature of NASH pathogenesis [95].”
BackgroundKnockdown of ferroportin accelerates erastin-induced ferroptosis in neuroblastoma cells.
Geng, N., Shi, B.-J., Li, S.-L., Zhong, Z., Li, Y.-C., Xua, W., Zhou, H., & Cai, J.-H. (2018) · European Review for Medical and Pharmacological Sciences · doi:10.26355/eurrev_201806_15267 · Cited by 281 · cited 1×
“In the non-canonical pathway, increased iron uptake by transferrin receptor (TFRC) and reduced iron export by ferroportin promote oxidative damage and ferroptosis [60, 61].”
BackgroundIbrahim, S. H., Hirsova, P., & Gores, G. J. (2018) · Gut · doi:10.1136/gutjnl-2017-315691 · Cited by 278 · cited 1×
“Finally, we note that cell death per se may be a biomarker for stressed, proinflammatory hepatocytes as recently suggested in NASH [142], and therefore, precluding cell death may not have the major impact on liver injury that we anticipate.”
BackgroundSelf-citationGasdermins and their role in immunity and inflammation
Ørning, P., Lien, E., & Fitzgerald, K. A. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20190545 · Cited by 277 · cited 1×
“Cleave of GSDMD occurs via a canonical inflammasome caspase-1 dependent mechanism, a non-canonical inflammasome pathway involving caspases 4, 5 or 11 [139], or in an inflammasome-independent caspase-8 mediated pathway [140].”
BackgroundNLRP3 inflammasome driven liver injury and fibrosis: roles of IL-17 and TNF in mice
Wree, A., McGeough, M. D., Inzaugarat, M. E., Eguchi, A., Schuster, S., Johnson, C. D., Peña, C. A., Geisler, L. J., Papouchado, B. G., Hoffman, H. M., et al. (2018) · Hepatology · doi:10.1002/hep.29523 · Cited by 266 · cited 1×
“Thus, in addition to immune cells, hepatocyte pyroptosis resulting from intrinsic inflammasome activation exacerbates inflammation and fibrosis in the liver, indicating that both immune cell- and liver-specific NLRP3 inflammasome activation are essential for liver injury [101, 102].”
BackgroundCaspase-8 scaffolding function and MLKL regulate NLRP3 inflammasome activation downstream of TLR3
Kang, S., Fernandes‐Alnemri, T., Rogers, C., Mayes, L., Wang, Y., Dillon, C. P., Roback, L., Kaiser, W. J., Oberst, A., Sagara, J., et al. (2015) · Nature Communications · doi:10.1038/ncomms8515 · Cited by 263 · cited 1×
“In addition to its enzymatic role in apoptosis and necroptosis, caspase-8 acts as a scaffolding protein that together with MLKL regulates NLRP3 inflammasome activation in macrophages [69].”
BackgroundA randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis
Harrison, S. A., Goodman, Z., Jabbar, A., Vemulapalli, R., Younes, Z. H., Freilich, B., Sheikh, M. Y., Schattenberg, J. M., Kayali, Z., Zivony, A., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.11.024 · Cited by 260 · cited 1×
“Recently reported, caspase inhibition with Emricasan treatment did not improve clinical outcomes nor liver histology in patients with NASH fibrosis, resulting in more liver fibrosis and hepatocyte ballooning [143, 144].”
BackgroundHeo, M. J., Kim, T. H., You, J. S., Blaya, D., Sancho‐Bru, P., & Kim, S. G. (2018) · Gut · doi:10.1136/gutjnl-2017-315123 · Cited by 256 · cited 1×
“demonstrated that alcohol elicits caspase-1-mediated pyroptosis through overexpression of thioredoxin-interacting protein (TXNIP), a member of the α-arrestin family, and this event is reversed by miR-148a [124].”
BackgroundRIP kinases as modulators of inflammation and immunity
He, S., & Wang, X. (2018) · Nature Immunology · doi:10.1038/s41590-018-0188-x · Cited by 250 · cited 2×
“For example, RIP kinases have diverse functions in addition to promoting necroptosis [90].”
BackgroundPyroptosis by caspase11/4‐gasdermin‐D pathway in alcoholic hepatitis in mice and patients
Khanova, E., Wu, R., Wang, W., Yan, R., Chen, Y., French, S. W., Llorente, C., Pan, S. Q., Yang, Q., Li, Y., et al. (2018) · Hepatology · doi:10.1002/hep.29645 · Cited by 228 · cited 1×
“Consistently, NLRP3 deficiency ameliorated alcohol-driven liver stetaosis and injury [120], while caspase-4/11 was upregulated in liver tissue from patients with alcoholic hepatitis and in mice [121].”
BackgroundAfonso, M. B., Rodrigues, P. M., Carvalho, T., Caridade, M., Borralho, P., Cortez‐Pinto, H., Castro, R. E., & Rodrigues, C. M. P. (2015) · Clinical Science · doi:10.1042/cs20140732 · Cited by 219 · cited 2×
“Interestingly, RIPK3 deficiency protected from liver injury, inflammation and fibrosis in MCD-fed mice [74, 75], but exacerbated liver steatosis and apoptosis, as well as adipose tissue inflammation, insulin resistance and glucose intolerance induced by high-fat diet [79, 81].”
BackgroundSelf-citationMolecular crosstalk between apoptosis, necroptosis, and survival signaling
Berghe, T. V., Kaiser, W. J., Bertrand, M. J. M., & Vandenabeele, P. (2015) · Molecular & Cellular Oncology · doi:10.4161/23723556.2014.975093 · Cited by 209 · cited 1×
“There are considerable crosstalk regulations between apoptosis and necroptosis in DR signalling pathways [21], and it seems that one cannot be achieved without inhibiting the other.”
BackgroundBrault, M., Olsen, T. M., Martinez, J., Stetson, D. B., & Oberst, A. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701492 · Cited by 195 · cited 3×
“Schock SN, Chandra NV, Sun Y, Irie T, Kitagawa Y, Gotoh B, et al. Induction of necroptotic cell death by viral activation of the RIG-I or STING pathway.”
BackgroundZargarian, S., Shlomovitz, I., Erlich, Z., Hourizadeh, A., Ofir‐Birin, Y., Croker, B. A., Regev‐Rudzki, N., Edry‐Botzer, L., & Gerlic, M. (2017) · PLoS Biology · doi:10.1371/journal.pbio.2002711 · Cited by 194 · cited 1×
“Finally, MLKL forms pore in the plasma membrane [16, 17], and increases permeability via the activation of A disintegrin and metalloproteinase (ADAM) proteases [18], Ca2+ influx by targeting the cation channel transient receptor potential melastatin related 7 (TRPM7) [19], and phosphatidylserine externalization [20].”
BackgroundBrumatti, G., Ma, C., Lalaoui, N., Nguyen, N.-Y. N., Navarro, M., Tanzer, M. C., Richmond, J., Ghisi, M., Salmon, J. M., Silke, N., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad3099 · Cited by 190 · cited 1×
“Indeed, Emricasan has previously been shown to shift cell death from apoptosis towards necroptosis in acute myeloid leukemia cells treated with birinapant, a second mitochondrial derived activator of caspases mimetic, which enhances cancer cell apoptosis [145].”
BackgroundLinking Pathogenic Mechanisms of Alcoholic Liver Disease With Clinical Phenotypes
Nagy, L. E., Ding, W., Cresci, G., Saikia, P., & Shah, V. H. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.035 · Cited by 186 · cited 9×
“Importantly, crossregulation by the effectors of different cell death pathways most likely influences liver inflammation in ALD.”
BackgroundInfluentialLoguercio, C., Girolamo, V. D., de Sio, I., Tuccillo, C., Ascione, A., Baldi, F., Budillon, G., Cimino, L., Carlo, A. D., Marino, M. D. D., et al. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00192-1 · Cited by 186 · cited 1×
“Nevertheless, secondary products of lipid peroxidation, such as malondialdehyde and 4-hydroxinonenal are utilized as oxidative stress markers in NASH patients [103], and Vitamin E, an antioxidant that suppresses lipid peroxidation, reduces serum ALT in NASH patients [104].”
BackgroundRIPK3 as a potential therapeutic target for Gaucher's disease
Vitner, E. B., Salomon, R., Farfel‐Becker, T., Meshcheriakova, A., Ali, M., Klein, A. D., Platt, F. M., Cox, T. M., & Futerman, A. H. (2014) · Nature Medicine · doi:10.1038/nm.3449 · Cited by 165 · cited 1×
“In striking contrast, RIPK3-mediated necroptosis has been implicated in pathology of Gaucher’s disease [132].”
BackgroundGarcía–Tsao, G., Bosch, J., Kayali, Z., Harrison, S. A., Abdelmalek, M. F., Lawitz, E., Satapathy, S. K., Ghabril, M., Shiffman, M. L., Younes, Z. H., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.12.010 · Cited by 158
Receptor interacting protein 3 protects mice from high‐fat diet‐induced liver injury
Roychowdhury, S., McCullough, R. L., Sanz‐García, C., Saikia, P., Alkhouri, N., Matloob, A., Pollard, K. A., McMullen, M. R., Croniger, C. M., & Nagy, L. E. (2016) · Hepatology · doi:10.1002/hep.28676 · Cited by 154 · cited 2×
“Interestingly, RIPK3 deficiency protected from liver injury, inflammation and fibrosis in MCD-fed mice [74, 75], but exacerbated liver steatosis and apoptosis, as well as adipose tissue inflammation, insulin resistance and glucose intolerance induced by high-fat diet [79, 81].”
BackgroundPetrášek, J., Iracheta‐Vellve, A., Saha, B., Satishchandran, A., Kodys, K., Fitzgerald, K. A., Kurt‐Jones, E. A., & Szabó, G. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ab1214-590r · Cited by 153 · cited 2×
“Consistently, NLRP3 deficiency ameliorated alcohol-driven liver stetaosis and injury [120], while caspase-4/11 was upregulated in liver tissue from patients with alcoholic hepatitis and in mice [121].”
BackgroundMajdi, A., Aoudjehane, L., Ratziu, V., Islam, T., Afonso, M. B., Conti, F., Mestiri, T., Lagouge, M., Foufelle, F., Ballenghien, F., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.11.008 · Cited by 148
Self-citationKang, Y. J., Bang, B., Han, K. H., Hong, L., Shim, E.-J., Ma, J., Lerner, R. A., & Otsuka, M. (2015) · Nature Communications · doi:10.1038/ncomms9371 · Cited by 146 · cited 1×
“RIPK3-deficient natural killer cells showed impaired immune responses to tumours and liver inflammation [88].”
BackgroundBoaru, S. G., Borkham‐Kamphorst, E., Tihaa, L., Haas, U., & Weiskirchen, R. (2012) · Journal of Inflammation · doi:10.1186/1476-9255-9-49 · Cited by 142 · cited 1×
“The NLRP3 inflammasome pathway is activated in hepatocytes in response to endotoxin challenge, a condition facilitated by alcohol intake [119].”
BackgroundInduction of necroptotic cell death by viral activation of the RIG-I or STING pathway
Schock, S., Chandra, N. V., Sun, Y., Irie, T., Kitagawa, Y., Gotoh, B., Coscoy, L., & Winoto, A. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2016.153 · Cited by 141 · cited 2×
“The activation of necroptosis is not limited to DRs, and it can be triggered by multiple pathways, including toll-like receptors (e.g., TLR3 and TLR4) [26], nucleic acid sensors (e.g., Z-DNA-binding protein 1 [ZBP1, also known as DAI]) [27], retinoic acid inducible gene 1 protein (RIG1) [28], transmembrane protein 173…”
BackgroundProgrammed Cell Death and Inflammation: Winter Is Coming
Kolb, J. P., Oguin, T. H., Oberst, A., & Martinez, J. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.06.009 · Cited by 136 · cited 1×
“, ferroptosis), their chronic stimulation can lead to an excessive inflammation that may be detrimental and start damaging healthy cells, tissues, and organs [62].”
BackgroundNon-alcoholic fatty liver disease and the interface between primary and secondary care
Tsochatzis, E. A., & Newsome, P. N. (2018) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(18)30077-3 · Cited by 130 · cited 1×
“NAFLD is estimated to affect up to one-third of the general population worldwide [71].”
BackgroundActivation of necroptosis in human and experimental cholestasis
Afonso, M. B., Rodrigues, P. M., Simão, A. L., Ofengeim, D., Carvalho, T., Amaral, J. D., Gaspar, M. M., Cortez‐Pinto, H., Castro, R. E., Yuan, J., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.280 · Cited by 129
Self-citationVucur, M., Reisinger, F., Gautheron, J., Janssen, J., Roderburg, C., Cardenas, D. V., Kreggenwinkel, K., Koppe, C., Hammerich, L., Hakem, R., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.07.035 · Cited by 127 · cited 1×
“Other functions of RIPK3 in hepatocarcinogenesis have been recognized [85], and its involvement in inflammatory signalling independent of necroptosis and mediation of cell death should not be neglected [86, 87].”
BackgroundSelf-citationLiver Fibrosis in Alcoholic Liver Disease
Bataller, R., & Gao, B. (2015) · Seminars in liver disease (Print) · doi:10.1055/s-0035-1550054 · Cited by 114 · cited 1×
“Alcohol-associated liver disease (ALD) is a major health problem worldwide and a significant source of liver injury, characterized by a wide spectrum of hepatic lesions from steatosis, steatohepatitis and fibrosis that may progress to cirrhosis and even hepatocellular carcinoma [112].”
BackgroundThe pseudokinase MLKL regulates hepatic insulin sensitivity independently of inflammation
Xu, H., Du, X., Liu, G., Huang, S., Du, W., Zou, S., Tang, D., Fan, C., Xie, Y., Wei, Y., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.02.003 · Cited by 112 · cited 1×
“High levels of core components of necroptosis were detected in liver, adipose tissue and muscle in diabetic mice, whereas targeting diabetic mice with RIPK1 inhibitors or depletion of MLKL prevented insulin resistance and glucose intolerance, despite no effect on inflammation [80].”
BackgroundCurrent translational potential and underlying molecular mechanisms of necroptosis
Molnár, T., Mázló, A., Tslaf, V., Szöllősi, A. G., Emri, G., & Koncz, G. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2094-z · Cited by 110 · cited 2×
“MLKL inhibitors are being developed such as necrosulfonamide, which binds to the N-terminal 4 helical bundle of MLKL to prevent necroptosis [146, 147].”
BackgroundmiRNA-21 ablation protects against liver injury and necroptosis in cholestasis
Afonso, M. B., Rodrigues, P. M., Simão, A. L., Gaspar, M. M., Carvalho, T., Borralho, P., Bañales, J. M., Castro, R. E., & Rodrigues, C. M. P. (2017) · Cell Death and Differentiation · doi:10.1038/s41418-017-0019-x · Cited by 109 · cited 1×
“Similarly, in common bile duct ligation hepatic injury, necroptosis was induced and contributed to fibrosis [82], although the effects of necroptosis inhibition on different hepatic fibrosis models are yet to be consistently determined.”
BackgroundSelf-citationThe necroptosis-inducing kinase RIPK3 dampens adipose tissue inflammation and glucose intolerance
Gautheron, J., Vucur, M., Schneider, A. T., Severi, I., Roderburg, C., Roy, S., Bartneck, M., Schrammen, P. L., Díaz, M. B., Ehling, J., et al. (2016) · Nature Communications · doi:10.1038/ncomms11869 · Cited by 106
Self-citationActivation of cell-surface proteases promotes necroptosis, inflammation and cell migration
Cai, Z., Zhang, A., Choksi, S., Li, W., Li, T., Zhang, X.-M., & Liu, Z.-G. (2016) · Cell Research · doi:10.1038/cr.2016.87 · Cited by 103 · cited 1×
“Finally, MLKL forms pore in the plasma membrane [16, 17], and increases permeability via the activation of A disintegrin and metalloproteinase (ADAM) proteases [18], Ca2+ influx by targeting the cation channel transient receptor potential melastatin related 7 (TRPM7) [19], and phosphatidylserine externalization [20].”
BackgroundQuestions and controversies: the role of necroptosis in liver disease
Dara, L., Liu, Z., & Kaplowitz, N. (2016) · Cell Death Discovery · doi:10.1038/cddiscovery.2016.89 · Cited by 100 · cited 2×
“First, there is vigorous controversy regarding the expression of RIPK3 by hepatocytes, but under basal conditions expression appears to be quite limited [135, 136].”
BackgroundNrf2 Knockdown Disrupts the Protective Effect of Curcumin on Alcohol-Induced Hepatocyte Necroptosis
Lu, C., Xu, W., Zhang, F., Shao, J., & Zheng, S. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00562 · Cited by 98 · cited 1×
“Other studies reported that ethanol-induced decrease of Nrf2 expression was abrogated by curcumin or gallic acid treatment, by suppressing RIPK3 and RIPK1 expression as well as DAMP release [116, 117].”
BackgroundWang, S., Ni, H., Dorko, K., Kumer, S. C., Schmitt, T. M., Nawabi, A. M., Komatsu, M., Huang, H., & Ding, W. (2016) · Oncotarget · doi:10.18632/oncotarget.6893 · Cited by 91 · cited 3×
“Nevertheless, inhibition of RIP1 kinase activity blunted Gao-binge alcohol-induced hepatic inflammation but did not protect against chronic ethanol feeding-induced steatosis and liver injury, suggesting that alcohol-induced RIPK3-mediated necroptosis is independent of RIPK1 [114].”
BackgroundNeutrophil Necroptosis Is Triggered by Ligation of Adhesion Molecules following GM-CSF Priming
Wang, X., He, Z., Liu, H., Yousefi, S., & Simon, H. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600051 · Cited by 88 · cited 1×
“, Z-DNA-binding protein 1 [ZBP1, also known as DAI]) [27], retinoic acid inducible gene 1 protein (RIG1) [28], transmembrane protein 173 (TMEM173, also known as STING) [29], and adhesion receptors [30].”
BackgroundIron-Induced Liver Injury: A Critical Reappraisal
Bloomer, S. A., & Brown, K. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092132 · Cited by 87 · cited 1×
“Iron-induced liver damage is likely potentiated by coexisting inflammation, which culminates with hepatocyte cell death and drives fibrogenesis [127].”
BackgroundRay, C., & Pickup, D. (1996) · Virology · doi:10.1006/viro.1996.0128 · Cited by 86 · cited 1×
“the expression of the viral cytokine response modifier A (CrmA), a caspase inhibitor [5].”
BackgroundNecrosis-dependent and independent signaling of the RIP kinases in inflammation
Moriwaki, K., & Chan, F. K.-M. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.12.013 · Cited by 84 · cited 1×
“Other functions of RIPK3 in hepatocarcinogenesis have been recognized [85], and its involvement in inflammatory signalling independent of necroptosis and mediation of cell death should not be neglected [86, 87].”
BackgroundValenti, L. V. C., Moscatiello, S., Vanni, E., Fracanzani, A. L., Bugianesi, E., Fargion, S. R., & Marchesini, G. (2010) · QJM · doi:10.1093/qjmed/hcq170 · Cited by 82 · cited 5×
“Ablation of Ripk3 resulted in fewer CD68-positive Kupffer cells and decreased ALT activity, suggesting that hepatocyte injury was also attenuated.”
BackgroundInfluentialAizawa, S., Brar, G., & Tsukamoto, H. (2019) · Gut and Liver · doi:10.5009/gnl18486 · Cited by 80
Ni, H., Chao, X., Kaseff, J., Deng, F., Wang, S., Shi, Y., Li, T., Ding, W., & Jaeschke, H. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.03.010 · Cited by 72 · cited 1×
“RIPK3MLKL-mediated necroptosis contributed also to ischemia reperfusion injury of steatotic livers [83].”
BackgroundZhou, Z., Ye, T.-J., Bonavita, G., Daniels, M., Kainrad, N., Jogasuria, A. P., & You, M. (2019) · Hepatology Communications · doi:10.1002/hep4.1333 · Cited by 64
Hanna-Addams, S., Liu, S., Liu, H., Chen, S., & Wang, Z. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1917112117 · Cited by 58
Necroptosis in Niemann–Pick disease, type C1: a potential therapeutic target
Cougnoux, A., Cluzeau, C. V. M., Mitra, S., Li, R., Williams, I. M., Burkert, K. R., Xu, X., Wassif, C. A., Zheng, W., & Porter, F. D. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.16 · Cited by 58 · cited 2×
“Nevertheless, corroborating the role of alternative RCD sub-routines, cellular death of NPC1 fibroblasts was not mitigated by treatment with caspase inhibitors [129] or following neuronal overexpression of Bcl-2 [130].”
BackgroundStudies on neuronal death in the mouse model of Niemann‐Pick C disease
Erickson, R., & Bernard, O. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10257 · Cited by 55 · cited 1×
“Nevertheless, corroborating the role of alternative RCD sub-routines, cellular death of NPC1 fibroblasts was not mitigated by treatment with caspase inhibitors [129] or following neuronal overexpression of Bcl-2 [130].”
BackgroundGasdermin D protects against noninfectious liver injury by regulating apoptosis and necroptosis
Yang, C., Sun, P., Deng, M., Loughran, P., Li, W., Yi, Z., Li, S., Zhang, X., Fan, J., Billiar, T. R., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1719-6 · Cited by 54 · cited 1×
“Interestingly, in shock models of liver injury, GSDMD germ line deficient mice display increased caspase-8 activation and apoptosis in the liver [141].”
BackgroundSaeed, W. K., Jun, D. W., Jang, K., Oh, J., Chae, Y. J., Lee, J. S., Koh, D. H., & Kang, H. T. (2019) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14740 · Cited by 51 · cited 1×
“Similarly, MLKL pharmacological inhibition decreased hepatic de novo fat synthesis and chemokine ligand expression in NASH [91].”
BackgroundGallic acid protects against ethanol-induced hepatocyte necroptosis via an NRF2-dependent mechanism
Zhou, Y., Jin, H., Wu, Y. C., Chen, L., Bao, X., & Lu, C. (2019) · Toxicology in Vitro · doi:10.1016/j.tiv.2019.03.008 · Cited by 46 · cited 1×
“Other studies reported that ethanol-induced decrease of Nrf2 expression was abrogated by curcumin or gallic acid treatment, by suppressing RIPK3 and RIPK1 expression as well as DAMP release [116, 117].”
BackgroundThe Receptor Interacting Protein Kinases in the Liver
Dara, L. (2018) · Seminars in Liver Disease · doi:10.1055/s-0038-1629924 · Cited by 43
The inflammasome in alcoholic hepatitis: its relationship with Mallory-Denk body formation
Peng, Y., French, B., Tillman, B., Morgan, T., & French, S. (2014) · Experimental and molecular pathology (Print) · doi:10.1016/j.yexmp.2014.08.006 · Cited by 43 · cited 1×
“Caspase-1 was also activated in hepatocytes of patients with alcoholic hepatitis [123].”
BackgroundZhang, Z., Xie, G., Li, L., Liu, H., Pan, J., Cheng, H., Wang, H., Qu, A., & Wang, Y. (2018) · Journal of Immunology Research · doi:10.1155/2018/1509851 · Cited by 40
Köhn‐Gaone, J., Dwyer, B. J., Grzelak, C. A., Miller, G. C., Shackel, N. A., Ramm, G. A., McCaughan, G. W., Elsegood, C. L., Olynyk, J. K., & Tirnitz‐Parker, J. E. E. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.03.005 · Cited by 38 · cited 1×
“In a recent study, ferroptosis inhibitors, trolox and deferiprone, suppressed necrotic cell death, infiltration of inflammatory cells, and inflammatory cytokine expression in the onset of steatohepatitis in the choline-deficient, ethionine-supplemented (CDE) diet model [108], in which hepatic cell death is an early ev…”
BackgroundNecroptosis in Nonalcoholic Steatohepatitis
Gautheron, J., Vucur, M., & Luedde, T. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.02.001 · Cited by 35
Self-citationRescue from a fiery death: A therapeutic endeavor
Kayagaki, N., & Dixit, V. (2019) · Science · doi:10.1126/science.aaw1177 · Cited by 35 · cited 2×
“Cleave of GSDMD occurs via a canonical inflammasome caspase-1 dependent mechanism, a non-canonical inflammasome pathway involving caspases 4, 5 or 11 [139], or in an inflammasome-independent caspase-8 mediated pathway [140].”
BackgroundKrishna-Subramanian, S., Singer, S., Armaka, M., Bañales, J. M., Hölzer, K., Schirmacher, P., Walczak, H., Kollias, G. A., Pasparakis, M., & Kondylis, V. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0330-9 · Cited by 35 · cited 3×
“Third, caspase-8 limits necroptosis by proteolytically cleaving RIPK1 [138], and the genetic absence of caspase-8 in hepatocytes does not trigger widespread necroptosis [134].”
BackgroundCougnoux, A., Clifford, S., Salman, A., Ng, S.-L., Bertin, J., & Porter, F. (2018) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2018.10.009 · Cited by 29
Processes exacerbating apoptosis in non-alcoholic steatohepatitis
Afonso, M. B., Castro, R. E., & Rodrigues, C. M. P. (2019) · Clinical Science · doi:10.1042/cs20190068 · Cited by 25 · cited 1×
“Indeed, lipotoxicity, oxidative stress, organelle dysfunction and inflammatory response exacerbate ballooning and increase hepatocyte cell death [73].”
BackgroundSelf-citationUnderstanding allosteric interactions in hMLKL protein that modulate necroptosis and its inhibition
Bansal, N., Sciabola, S., & Bhisetti, G. (2019) · Scientific Reports · doi:10.1038/s41598-019-53078-5 · Cited by 24 · cited 1×
“MLKL inhibitors are being developed such as necrosulfonamide, which binds to the N-terminal 4 helical bundle of MLKL to prevent necroptosis [146, 147].”
Research works printed but not linked: 1
- Orning, 2019, Gasdermins and their role in immunity and inflammation, J Exp Med, 216, 2453, 10.1084/jem.20190545 · DOI
Cited by
Sorted by citations
The multifaceted role of ferroptosis in liver disease
Chen, J., Li, X., Ge, C., Min, J., & Wang, F. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00941-0 · Cited by 683
How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
Geng, Y., Faber, K. N., de Meijer, V. E., Blokzijl, H., & Moshage, H. J. (2021) · Hepatology International · doi:10.1007/s12072-020-10121-2 · Cited by 465
Oxidative stress and regulated cell death in Parkinson’s disease
Dionísio, P. A., Amaral, J. D., & Rodrigues, C. M. P. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101263 · Cited by 443
Self-citationXu, X., Poulsen, K. L., Wu, L., Liu, S., Miyata, T., Song, Q., Wei, Q., Zhao, C., Lin, C., & Yang, J. B. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01119-3 · Cited by 387
“Multiple types of cell death, including apoptosis, necroptosis, pyroptosis, and ferroptosis, as well as autophagy, are associated with the development of NAFL/ NASH.(72,293,294) Among targeting different formats of cell death, inhibition of apoptosis has achieved promising results, here we focus on anti-apoptosis agen…”
BackgroundInfluentialFerroptosis in Liver Diseases: An Overview
Capelletti, M. M., Manceau, H., Puy, H., & Peoc’h, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144908 · Cited by 369
“New studies focused on the molecular basis of ferroptosis could help in deciphering the existing connections between the single components of the metabolic pathway.”
BackgroundInfluential
Metadata
- Authors
- Gautheron, J., Gores, G. J., & Rodrigues, C. M. P.
- Affiliations
- Inserm (FR)
- Mayo Clinic (US)
- University of Lisbon (PT)
- Corresponding author
- Rodrigues, Cecília M.P.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2020-08
- Volume
- 73
- Issue
- 2
- Pages
- 394-408
- ISSN
- 0168-8278 (ISSN-L)
- PMC
- PMC7371520
- OpenAlex
- W3016394009
- Cited by
- 225
- References
- 148
- Citations by year
- 2026: 31 · 2025: 32 · 2024: 49 · 2023: 40 · 2022: 42 · 2021: 23 · 2020: 8
- FWCI
- 2.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Hepatology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion, other-oa)
- Funders
- Fondation pour la Recherche Médicale
- Fundação para a Ciência e a Tecnologia
- National Institutes of Health
- H2020 Marie Skłodowska-Curie Actions
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- lytic cell death, metabolic liver disease, pyroptosis, ferroptosis, apoptosis, liver inflammation, liver fibrosis, liver cirrhosis, hepatic stellate cells, non-alcoholic fatty liver disease, alcoholic liver disease, therapeutic target
- MeSH terms
- Pyroptosis, Necroptosis, Ferroptosis, Regulated Cell Death, Humans, Liver Diseases, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review